Cytotoxic drugs
Malignant Disease and Immunosuppression | BNF Section 0801
Items (National)
191.2K
NHS Cost
£5.5M
Substances
31
Drugs in Cytotoxic drugs
| Drug | Items (National) | Cost | Practices |
|---|---|---|---|
| Hydroxycarbamide | 89.1K | £959.7K | 3,090 |
| Mercaptopurine | 54.1K | £1.2M | 3,496 |
| Methotrexate | 40.7K | £2.6M | 1,366 |
| Fluorouracil (Antimetabolites) | 4,319 | £136.3K | 1,281 |
| Calcium folinate | 2,743 | £500.3K | 349 |
| Imatinib mesilate | 36 | £25.7K | 13 |
| Ruxolitinib | 23 | £12.2K | 6 |
| Tioguanine | 22 | £1.2K | 3 |
| Cyclophosphamide | 17 | £1.0K | 13 |
| Tretinoin | 16 | £7.0K | 4 |
| Mesna | 12 | £1.9K | 2 |
| Busulfan | 8 | £100 | 4 |
| Procarbazine hydrochloride | 8 | £3.2K | 7 |
| Nintedanib | 7 | £11.8K | 4 |
| Mitotane | 7 | £7.9K | 2 |
| Everolimus | 6 | £4.5K | 5 |
| Abemaciclib | 6 | £16.2K | 4 |
| Capecitabine | 4 | £21 | 2 |
| Temozolomide | 4 | £321 | 2 |
| Ibrutinib | 3 | £12.9K | 3 |
| Chlorambucil | 2 | £22 | 1 |
| Bexarotene | 1 | £591 | 1 |
| Temoporfin | 1 | £6.8K | 1 |
| Dasatinib | 1 | £21 | 1 |
| Nilotinib | 1 | £22 | 1 |
| Vandetanib | 1 | £5.0K | 1 |
| Cabozantinib | 1 | £5.1K | 1 |
| Olaparib | 1 | £41 | 1 |
| Osimertinib | 1 | £5.1K | 1 |
| Ribociclib | 1 | £47 | 1 |
| Zanubrutinib | 1 | £4.9K | 1 |